CHEGAEV, Konstantin
 Distribuzione geografica
Continente #
EU - Europa 2.379
NA - Nord America 2.002
AS - Asia 1.062
AF - Africa 64
SA - Sud America 52
OC - Oceania 27
Continente sconosciuto - Info sul continente non disponibili 3
Totale 5.589
Nazione #
US - Stati Uniti d'America 1.937
DE - Germania 900
IT - Italia 517
CN - Cina 389
IN - India 224
GB - Regno Unito 213
FR - Francia 119
RU - Federazione Russa 92
RO - Romania 85
KR - Corea 82
NL - Olanda 74
JP - Giappone 71
VN - Vietnam 66
AT - Austria 58
UA - Ucraina 52
CA - Canada 47
PL - Polonia 46
CZ - Repubblica Ceca 45
IR - Iran 44
EG - Egitto 30
SE - Svezia 30
TR - Turchia 30
IE - Irlanda 29
BR - Brasile 28
ID - Indonesia 28
ES - Italia 27
AU - Australia 25
HK - Hong Kong 19
TW - Taiwan 19
SY - Repubblica araba siriana 15
PK - Pakistan 13
CH - Svizzera 12
SG - Singapore 12
ZA - Sudafrica 12
FI - Finlandia 11
MX - Messico 11
TH - Thailandia 10
GR - Grecia 9
PT - Portogallo 9
CO - Colombia 8
HU - Ungheria 8
IL - Israele 8
BG - Bulgaria 7
DK - Danimarca 7
DZ - Algeria 6
JO - Giordania 6
CU - Cuba 5
IQ - Iraq 5
KE - Kenya 5
UY - Uruguay 5
HR - Croazia 4
NG - Nigeria 4
NO - Norvegia 4
AE - Emirati Arabi Uniti 3
AR - Argentina 3
BE - Belgio 3
CL - Cile 3
CY - Cipro 3
EC - Ecuador 3
LT - Lituania 3
SA - Arabia Saudita 3
AL - Albania 2
EU - Europa 2
GH - Ghana 2
LV - Lettonia 2
MA - Marocco 2
MK - Macedonia 2
MY - Malesia 2
NZ - Nuova Zelanda 2
PE - Perù 2
PH - Filippine 2
RS - Serbia 2
SI - Slovenia 2
UZ - Uzbekistan 2
A1 - Anonimo 1
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BF - Burkina Faso 1
BY - Bielorussia 1
CR - Costa Rica 1
EE - Estonia 1
GE - Georgia 1
GT - Guatemala 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LK - Sri Lanka 1
MD - Moldavia 1
MO - Macao, regione amministrativa speciale della Cina 1
SD - Sudan 1
SK - Slovacchia (Repubblica Slovacca) 1
TN - Tunisia 1
Totale 5.589
Città #
Torino 219
Houston 199
Fairfield 170
Ashburn 126
Ann Arbor 122
Beijing 111
Buffalo 92
Woodbridge 88
Seattle 87
Santa Cruz 66
University Park 63
Cambridge 59
Wilmington 57
Vienna 54
Mountain View 46
Wuhan 43
Nürnberg 42
Dong Ket 35
Manchester 35
Hangzhou 33
Atherstone 30
Turin 28
Dublin 27
Fleming Island 27
Mumbai 27
Boardman 25
Nanjing 22
San Diego 21
Warsaw 21
Moscow 20
Council Bluffs 19
Lake Forest 19
Stockholm 19
Pisa 18
Chicago 17
Tokyo 17
Zhengzhou 16
Bengaluru 15
Guangzhou 15
Hanoi 15
Leawood 15
Shanghai 15
Toronto 15
Dearborn 14
Jinan 14
Las Vegas 14
New York 13
Taipei 13
Hyderabad 12
Siena 12
Jakarta 11
Los Angeles 11
Ottawa 11
Shenyang 11
Clarks Summit 10
Gurgaon 10
Helsinki 10
Paris 9
Athens 8
Brisbane 8
Brooklyn 8
Carrara 8
Chengdu 8
Henderson 8
Izmir 8
Madrid 8
Phoenix 8
Chandler 7
Frankfurt am Main 7
Harbin 7
Herndon 7
Lausanne 7
London 7
Milan 7
New Delhi 7
Portland 7
Pune 7
San Francisco 7
San Jose 7
Alessandria 6
Bangkok 6
Changchun 6
East Ham 6
Hamburg 6
Maisons-alfort 6
Mexico 6
Montréal 6
Mugnano di Napoli 6
Muizenberg 6
Naples 6
Rivoli 6
Rome 6
Seoul 6
Tappahannock 6
Taramani 6
Toledo 6
Towson 6
West Bromwich 6
Changsha 5
Clearwater 5
Totale 2.665
Nome #
Multitarget Drugs: Focus on the NO-donor hybrid drugs, file e27ce426-b4e8-2581-e053-d805fe0acbaa 333
Synthesis physicochemical profile and PAMPA study of new NO-donor edaravone co-drugs, file e27ce426-d83a-2581-e053-d805fe0acbaa 253
Mitochondrial-targeting nitrooxy-doxorubicin: a new approach to overcome drug resistance., file e27ce426-e3dd-2581-e053-d805fe0acbaa 252
Design, Synthesis, and Characterization of N-Oxide-Containing Heterocycles with in Vivo Sterilizing Antitubercular Activity, file e27ce42c-26e7-2581-e053-d805fe0acbaa 246
New nitric oxide or hydrogen sulfide releasing aspirins, file e27ce426-d99c-2581-e053-d805fe0acbaa 245
NO-Donor Phenols: A New Class of Products Endowed with Antioxidant and Vasodilator Properties, file e27ce426-aadd-2581-e053-d805fe0acbaa 229
Leishmanicidal Activity of Novel Synthetic Furoxan and Benzofuroxan Derivatives, file e27ce429-8b1b-2581-e053-d805fe0acbaa 229
Phenylsulfonylfuroxans as Modulators of Multidrug-Resistance-Associated Protein-1 and P-Glycoprotein, file e27ce426-c64d-2581-e053-d805fe0acbaa 196
Novel Antioxidant Agents Deriving From Molecular Combination of Vitamin C and NO-donor moieties, file e27ce426-aaa3-2581-e053-d805fe0acbaa 179
NO-donor COX-2 inhibitors. New nitrooxy-substituted 1,5-diarylimidazoles endowed with COX-2 inhibitory and vasodilator properties, file e27ce426-ae93-2581-e053-d805fe0acbaa 172
A Nitric Oxide-Donor Furoxan Moiety Improves the Efficacy of Edaravone against Early Renal Dysfunction and Injury Evoked by Ischemia/Reperfusion, file e27ce427-0dd8-2581-e053-d805fe0acbaa 163
Doxorubicin-antioxidant multitarget drugs, file e27ce426-f93b-2581-e053-d805fe0acbaa 144
Mitochondrial-targeting nitrooxy-doxorubicin: a new approach to overcome drug resistance., file e27ce426-e3df-2581-e053-d805fe0acbaa 139
Edaravone derivatives containing NO-donor functions, file e27ce426-bc77-2581-e053-d805fe0acbaa 135
Synthesis and Biological Evaluation of N2-Substituted 2,4-Diamino-6-cyclohexylmethoxy-5-nitrosopyrimidines and Related 5-Cyano-NNO-azoxy Derivatives as Cyclin-Dependent Kinase 2 (CDK2) Inhibitors, file e27ce429-3fcd-2581-e053-d805fe0acbaa 127
Structural and biological characterization of new hybrid drugs joining an HDAC inhibitor to different NO-donors, file e27ce42c-8704-2581-e053-d805fe0acbaa 126
NO-donor COX-2 inhibitors. New nitrooxy-substituted 1,5-diarylimidazoles endowed with COX-2 inhibitory and vasodilator properties, file e27ce426-ae92-2581-e053-d805fe0acbaa 111
Synthesis and biological activity of furoxan derivatives against Mycobacterium tuberculosis, file e27ce429-b98b-2581-e053-d805fe0acbaa 106
Overcoming multidrug resistance by targeting mitochondria with NO-donating doxorubicins, file e27ce428-7e0a-2581-e053-d805fe0acbaa 96
Liposomal Nitrooxy-Doxorubicin: One Step over Caelyx in Drug-Resistant Human Cancer Cells, file e27ce426-f58a-2581-e053-d805fe0acbaa 94
Mitochondrial delivery of phenol substructure triggers mitochondrial depolarization and apoptosis of cancer cells, file e27ce42c-f044-2581-e053-d805fe0acbaa 94
H2S-Donating Doxorubicins May Overcome Cardiotoxicity and Multidrug Resistance, file e27ce428-be10-2581-e053-d805fe0acbaa 92
(Nitrooxyacyloxy)methyl esters of aspirin as novel nitric oxide releasing aspirins, file e27ce426-b275-2581-e053-d805fe0acbaa 90
New tetrahydroisoquinoline derivatives overcome pgp activity in brain-blood barrier and glioblastoma multiforme in vitro, file e27ce42c-d292-2581-e053-d805fe0acbaa 81
New nitric oxide or hydrogen sulfide releasing aspirins, file e27ce426-d99d-2581-e053-d805fe0acbaa 72
Doxorubicin-antioxidant multitarget drugs, file e27ce426-f93a-2581-e053-d805fe0acbaa 70
Effects of Nitric Oxide Donor Antioxidants Containing the Phenol Vitamin E Substructure and a Furoxan Moiety on Ischemia/Riperfusion Injury, file e27ce426-bc73-2581-e053-d805fe0acbaa 66
NO-donor thiacarbocyanines as multifunctional agents for Alzheimer’s disease, file e27ce427-2d2f-2581-e053-d805fe0acbaa 66
Development of a new class of potential antiatherosclerosis agents: NO-donor antioxidants, file e27ce426-b11b-2581-e053-d805fe0acbaa 61
H2S-Donating Doxorubicins May Overcome Cardiotoxicity and Multidrug Resistance, file e27ce428-bf82-2581-e053-d805fe0acbaa 61
Phenylsulfonylfuroxans as Modulators of Multidrug-Resistance-Associated Protein-1 and P-Glycoprotein, file e27ce426-c64c-2581-e053-d805fe0acbaa 59
Furazan and furoxan sulfonamides are strong α-carbonic anhydrase inhibitors and potential antiglaucoma agents, file e27ce426-ef96-2581-e053-d805fe0acbaa 57
NO-Donor Melatonin Derivatives: Synthesis And In Vitro Pharmacological Characterization, file e27ce426-bbd1-2581-e053-d805fe0acbaa 56
Synthesis of Some Novel Organic Nitrates and Comparative in Vitro Study of Their Vasodilator Profile, file e27ce426-baef-2581-e053-d805fe0acbaa 50
Edaravone derivatives containing NO-donor functions, file e27ce426-bc79-2581-e053-d805fe0acbaa 50
Nitric Oxide Donor Doxorubicins Accumulate into Doxorubicin-Resistant Human Colon Cancer Cells Inducing Cytotoxicity, file e27ce426-c49d-2581-e053-d805fe0acbaa 50
Low concentrations of an nitric oxide-donor combined with a liposoluble antioxidant compound enhance protection against reperfusion injury in isolated rat hearts, file e27ce426-be73-2581-e053-d805fe0acbaa 49
New NO- and H2S-releasing doxorubicins as targeted therapy against chemoresistance in castration-resistant prostate cancer: in vitro and in vivo evaluations, file e27ce42c-fa2a-2581-e053-d805fe0acbaa 48
Direct introduction of cyano group on furoxan ring, file e27ce42c-6ab8-2581-e053-d805fe0acbaa 44
Galactosylated Pro-Drug of Ursodeoxycholic Acid: Design, Synthesis, Characterization, and Pharmacological Effects in a Rat Model of Estrogen-Induced Cholestasis, file e27ce42f-1217-2581-e053-d805fe0acbaa 44
Discovery of phenylsulfonylfuroxan derivatives as gamma globin inducers by histone acetylation, file e27ce42d-c537-2581-e053-d805fe0acbaa 41
Multitarget antioxidant NO-donor organic nitrates: a novel ap-proach to overcome nitrates tolerance, an ex vivo study, file e27ce434-a776-2581-e053-d805fe0acbaa 41
Endoplasmic reticulum-targeting doxorubicin: a new tool effective against doxorubicin-resistant osteosarcoma, file e27ce432-dd86-2581-e053-d805fe0acbaa 40
Multitarget Drugs: No-Donor Doxorubicins, file e27ce427-664a-2581-e053-d805fe0acbaa 36
New furoxan derivatives for the treatment of ocular hypertension, file e27ce42b-615d-2581-e053-d805fe0acbaa 36
Direct introduction of cyano group on furoxan ring, file e27ce42c-3791-2581-e053-d805fe0acbaa 34
Solid lipid nanoparticles carrying lipophilic derivatives of doxorubicin: preparation, characterization, and in vitro cytotoxicity studies, file e27ce42c-91c9-2581-e053-d805fe0acbaa 34
Hyaluronated liposomes containing H2S-releasing doxorubicin are effective against P-glycoprotein-positive/doxorubicin-resistant osteosarcoma cells and xenografts, file e27ce42e-af48-2581-e053-d805fe0acbaa 34
A Comprehensive Evaluation of Sdox, a Promising H2S-Releasing Doxorubicin for the Treatment of Chemoresistant Tumors, file e27ce435-6c36-2581-e053-d805fe0acbaa 34
New furoxan derivatives for the treatment of ocular hypertension, file e27ce42b-15a7-2581-e053-d805fe0acbaa 32
New tetrahydroisoquinoline-based P-glycoprotein modulators: Decoration of the biphenyl core gives selective ligands, file e27ce42d-8df5-2581-e053-d805fe0acbaa 32
Paracetamol-Galactose Conjugate: A Novel Prodrug for an Old Analgesic Drug, file e27ce435-98a8-2581-e053-d805fe0acbaa 29
Structure-Activity Relationship Studies on Tetrahydroisoquinoline Derivatives: [4′-(6,7-Dimethoxy-3,4-dihydro-1H-isoquinolin-2-ylmethyl)biphenyl-4-ol] (MC70) Conjugated through Flexible Alkyl Chains with Furazan Moieties Gives Rise to Potent and Selective Ligands of P-glycoprotein, file e27ce42a-1188-2581-e053-d805fe0acbaa 28
Light-Regulated NO Release as a Novel Strategy To Overcome Doxorubicin Multidrug Resistance, file e27ce42b-3a6a-2581-e053-d805fe0acbaa 28
Synthesis of Some Novel Organic Nitrates and Comparative in Vitro Study of Their Vasodilator Profile, file e27ce426-baf0-2581-e053-d805fe0acbaa 26
Screening for potential hazard effects from a multitarget anthracycline on the cardiovascular system, file e27ce427-a562-2581-e053-d805fe0acbaa 26
gem-Dinitroalkyl Benzenes: A Novel Class of IOP-Lowering Agents for the Treatment of Ocular Hypertension, file e27ce42c-8ff0-2581-e053-d805fe0acbaa 25
Light-Regulated NO Release as a Novel Strategy To Overcome Doxorubicin Multidrug Resistance, file e27ce42b-59af-2581-e053-d805fe0acbaa 23
Synthesis and biological activity of furoxan derivatives against Mycobacterium tuberculosis, file e27ce429-f403-2581-e053-d805fe0acbaa 22
Folate-targeted liposomal nitrooxy-doxorubicin: An effective tool against P-glycoprotein-positive and folate receptor-positive tumors, file e27ce433-469a-2581-e053-d805fe0acbaa 22
Nitric Oxide Donor Doxorubicins Accumulate into Doxorubicin-Resistant Human Colon Cancer Cells Inducing Cytotoxicity, file e27ce426-c49c-2581-e053-d805fe0acbaa 21
Multitarget Drugs: No-Donor Doxorubicins, file e27ce427-664b-2581-e053-d805fe0acbaa 21
MODIFIED DOXORUBICINS: "GASEOUS APPROACH" TO OVERCOME CARDIOTOXICITY AND MULTIDRUG RESISTANCE, file e27ce429-dd38-2581-e053-d805fe0acbaa 21
Folate-targeted liposomal nitrooxy-doxorubicin: An effective tool against P-glycoprotein-positive and folate receptor-positive tumors, file e27ce42c-ef0f-2581-e053-d805fe0acbaa 20
Planning, synthesis and anti-Mycobacterium tuberculosis activity of N-oxide derivatives, file e27ce42e-d34d-2581-e053-d805fe0acbaa 18
(Nitrooxyacyloxy)methyl esters of aspirin as novel nitric oxide releasing aspirins, file e27ce426-b276-2581-e053-d805fe0acbaa 16
NO-donor thiacarbocyanines as multifunctional agents for Alzheimer’s disease, file e27ce427-2d32-2581-e053-d805fe0acbaa 15
Synthesis and Biological Evaluation of N2-Substituted 2,4-Diamino-6-cyclohexylmethoxy-5-nitrosopyrimidines and Related 5-Cyano-NNO-azoxy Derivatives as Cyclin-Dependent Kinase 2 (CDK2) Inhibitors, file e27ce429-459c-2581-e053-d805fe0acbaa 15
Solid Lipid Nanoparticles Loaded with Antitumor Lipophilic Prodrugs Aimed to Glioblastoma Treatment: Preliminary Studies on Cultured Cells, file e27ce42b-0927-2581-e053-d805fe0acbaa 15
Endoplasmic reticulum-targeting doxorubicin: a new tool effective against doxorubicin-resistant osteosarcoma, file e27ce42e-1c89-2581-e053-d805fe0acbaa 15
INCAPSULATED NO-GEMCITABINE: GASEOUS SOLUTION FOR MDR PANCREATIC CANCER, file e27ce42e-7875-2581-e053-d805fe0acbaa 15
IN VITRO CARDIOVASCULAR TOXICITY RISK ASSESSMENT OF NOVEL H2S-DONATING ANTHRACYCLINE, file e27ce42c-332e-2581-e053-d805fe0acbaa 14
MRP5 nitration by NO-releasing gemcitabine encapsulated in liposomes confers sensitivity in chemoresistant pancreatic adenocarcinoma cells, file e27ce431-9d9c-2581-e053-d805fe0acbaa 14
Synthesis physicochemical profile and PAMPA study of new NO-donor edaravone co-drugs, file e27ce426-d83b-2581-e053-d805fe0acbaa 13
Solid lipid nanoparticles carrying lipophilic derivatives of doxorubicin: preparation, characterization, and in vitro cytotoxicity studies, file e27ce42a-2c87-2581-e053-d805fe0acbaa 13
Paracetamol-Galactose Conjugate: A Novel Prodrug for an Old Analgesic Drug, file e27ce42e-df97-2581-e053-d805fe0acbaa 12
Naked and Decorated Nanoparticles Containing H2S-Releasing Doxorubicin: Preparation, Characterization and Assessment of Their Antitumoral Efficiency on Various Resistant Tumor Cells, file 01a17931-38bf-4387-8a34-bfc4367cc146 8
N-[1,3-Dialkyl(aryl)-2-oxoimidazolidin-4-ylidene]-aryl(alkyl)sulphonamides as Novel Selective Human Cannabinoid Type 2 Receptor (hCB2R) Ligands; Insights into the Mechanism of Receptor Activation/Deactivation, file e260b6d2-2b05-4664-b2f5-644d7b2e365f 8
Overcoming multidrug resistance by targeting mitochondria with NO-donating doxorubicins, file e27ce428-7f7e-2581-e053-d805fe0acbaa 7
Folate-targeted liposomal nitrooxy-doxorubicin: An effective tool against P-glycoprotein-positive and folate receptor-positive tumors, file e27ce42c-a984-2581-e053-d805fe0acbaa 7
Use of Enzymatically Activated Carbon Monoxide Donors for Sensitizing Drug-Resistant Tumor Cells, file 3576b7e4-3057-45d2-bb29-862a088242ed 6
Light-Regulated NO Release as a Novel Strategy To Overcome Doxorubicin Multidrug Resistance, file e27ce42b-2369-2581-e053-d805fe0acbaa 6
MRP5 nitration by NO-releasing gemcitabine encapsulated in liposomes confers sensitivity in chemoresistant pancreatic adenocarcinoma cells, file e27ce431-259d-2581-e053-d805fe0acbaa 6
Comparative Study of Different H2S Donors as Vasodilators and Attenuators of Superoxide-Induced Endothelial Damage, file e80b50e2-8b98-45e7-9ee5-3d72ab9566e8 6
Endoplasmic reticulum-targeting doxorubicin: a new tool effective against doxorubicin-resistant osteosarcoma, file e27ce42e-0506-2581-e053-d805fe0acbaa 5
Galactosylated Pro-Drug of Ursodeoxycholic Acid: Design, Synthesis, Characterization, and Pharmacological Effects in a Rat Model of Estrogen-Induced Cholestasis, file e27ce42c-84fa-2581-e053-d805fe0acbaa 4
New tetrahydroisoquinoline-based P-glycoprotein modulators: Decoration of the biphenyl core gives selective ligands, file e27ce42c-f046-2581-e053-d805fe0acbaa 4
Multitarget antioxidant NO-donor organic nitrates: a novel approach to overcome nitrates tolerance, file 8a501c96-7179-442f-96a3-526d0ba798a8 3
(Nitrooxyacyloxy)methyl esters of aspirin as novel nitric oxide releasing aspirins, file e27ce426-b5e2-2581-e053-d805fe0acbaa 3
Mitochondrial-targeting nitrooxy-doxorubicin: a new approach to overcome drug resistance., file e27ce426-e3e0-2581-e053-d805fe0acbaa 3
Liposomal Nitrooxy-Doxorubicin: One Step over Caelyx in Drug-Resistant Human Cancer Cells, file e27ce426-f589-2581-e053-d805fe0acbaa 3
NO-donor thiacarbocyanines as multifunctional agents for Alzheimer’s disease, file e27ce427-3667-2581-e053-d805fe0acbaa 3
New furoxan derivatives for the treatment of ocular hypertension, file e27ce42b-615c-2581-e053-d805fe0acbaa 3
Galactosylated Pro-Drug of Ursodeoxycholic Acid: Design, Synthesis, Characterization, and Pharmacological Effects in a Rat Model of Estrogen-Induced Cholestasis, file e27ce42c-b575-2581-e053-d805fe0acbaa 3
New lipophilic organic nitrates: Candidates for chronic skin disease therapy, file ddc0baf1-1e37-458b-8507-13ee2406149a 2
Unsymmetrically Substituted Furoxans. Part 19. Methyl and Phenylfuroxansulfonic Acids and Related Sulfonamides, file e27ce426-b5e7-2581-e053-d805fe0acbaa 2
Doxorubicin-antioxidant multitarget drugs, file e27ce426-f93c-2581-e053-d805fe0acbaa 2
H2S-Donating Doxorubicins May Overcome Cardiotoxicity and Multidrug Resistance, file e27ce428-bf7d-2581-e053-d805fe0acbaa 2
gem-Dinitroalkyl Benzenes: A Novel Class of IOP-Lowering Agents for the Treatment of Ocular Hypertension, file e27ce42c-3c79-2581-e053-d805fe0acbaa 2
Aceclofenac-galactose conjugate: design, synthesis, characterization and pharmacological and toxicological evaluations, file e27ce42d-8dfb-2581-e053-d805fe0acbaa 2
Totale 5.816
Categoria #
all - tutte 9.620
article - articoli 0
book - libri 0
conference - conferenze 387
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 10.007


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019415 0 0 0 0 0 0 0 0 142 87 107 79
2019/2020894 97 80 75 154 74 52 78 48 75 60 48 53
2020/2021670 25 90 49 40 68 45 39 60 36 70 76 72
2021/2022851 62 44 69 144 97 51 68 41 58 53 119 45
2022/2023831 28 45 109 88 76 65 122 93 58 80 54 13
2023/2024206 35 28 21 24 19 19 34 18 8 0 0 0
Totale 5.838